Acellular Pertussis-Tetanus-Diphtheria Booster Vaccine

tetanus toxoids, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) · Novartis Vaccines

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Acellular Pertussis-Tetanus-Diphtheria Booster Vaccine, covering 2014-09-18 to 2014-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years [Phase 1]

See pricing